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Abstract 
This research was aimed to synthesize cinchonidine isobutyrate ester and 
conduct a preliminary assay for anticancer agent using cytotoxicity assay 
to Artemia salina Leach larva, or also known as brine shrimp lethality test 
(BSLT). Cinchonidine, a compound that has quinoline rings and 
quiniclidine ring, is a quinine analogue and stereoisomer of cinchonine. 
Cinchonidine is predicted to have anticancer activity. Synthesized ester 
was aimed to gain higher lipophilicity. Higher lipophilicity makes it easier 
for the compund to pass through cell membrane. The esterification 
process used DMAP as a catalyst, DCC as an activator, and isobutyric 
acid as a carboxilyc acid. Isobutyric acid is a type of short chained fatty 
acid that usually acts as an anticancer prodrugs. The product is identified 
by ESI-MS, FT-IR, 
1
H-NMR, dan 
13
C-NMR. Ester cinchonidine 
isobutyrate is gelatinous and colourless with yield of 21,77%. BSLT result 
showed that cinchonidine isobutyrate ester had LC50 value of 75.16 ppm 
which was more toxic than cinchonidine that had LC50 value of 99.2 ppm. 
It was proved that higher lipophilicity could increase pharmacology 
activity. 
© 2017 Indonesian Journal of Applied Chemistry. All rights reserved 
 
 
1. INTRODUCTION 
Cancer is a degenerative disease caused 
by abnormal cell growth and can spread and 
invade normal cells in the body. Cancer is 
one of the biggest causes of death in the 
world [1] (This encouraged the researchers to 
seek new chemo preventive agent with low 
systemic toxicity effects to minimize the 
occurrence of cancer therapy failure [2]. 
The ring of quinolone compounds has 
identified to have anti-cancer activity in 
addition to antimalarial and anti-
inflammatory [3]. Compounds that have 
quinolone ring such as quinine and its 
derivation has an effect on phase schizoints 
parasites and help take it out of the 
circulation. This compound also has the 
nature of gametocytocidal in Plasmodium 
vivax and P. malariae [4]. In addition, 
quinine and its derivatives also produce 
autophagy which is the process of solving the 
intracellular component through lysosome 
[5]. 
The autophagy ability could indicate 
cytotoxic properties of the compound. 
Quinacrine (quinine derivatives) can cause 
cell death via autophagy through the increase 
of p53 and p21 [6]. It was reported that 
quinine and its derivatives also had 
anticancer activity on breast, colon, lung, and 
glioma [7]. Quinine and its derivatives can 
also serve as triggers for apoptosis to MCF-7 
cells [8]. Quinine and its derivations have 
reached phase III clinical trial [9]. Beside 
quinine, cinchonine had also been reported to  
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Fig 1. Cinchona alkaloid and their basic skeleton. 
 
have cytotoxic properties against Chinese 
hamster ovary cancer cells (CHO) [10]. 
Cinchonidine, a compound that has 
quinolone ring, is a quinine analogue and 
stereoisomer of cinchonine [11] so that it is 
predicted have activity against cancer cells. 
Cinchonidine has also been observed to have 
non-toxic activity against normal fibroblast 
cells. On the other words, it is more selective 
than quinine [12]. 
Synthesis of esters using isobutyric acid 
was based on 3 reasons: it forms an ester 
prodrugs for the purpose of reaching the 
target and it is readily hydrolyzed [13], it is 
easily conducted on cinchonidine [14] and it 
has the right properties for anticancer drugs 
with special mechanisms and low toxicity 
[15]. 
The creation of this synthesis is also based 
on the Lipinski rule concerning the 
parameters of drug compounds that have an 
absorption or permeability. Cinchonidine 
isobutyrate was predicted by ChemDraw 
application to have log P value 4.05, 
molecular weight 364.22, 4 hydrogen bond 
acceptors, and no hydrogen bond donor, 
exactly as described in the Lipinski rule.  
It became the base for synthesis of 
cinchonidine isobutyrate esther. The toxicity 
value to artemia salina L larva was 
conducted using brine shrimp lethality test 
(BSLT) method. 
 
2. EXPERIMENTAL SECTION 
2. 1. Materials 
Cinchonidine was obtained from Local 
supplier (PT. Sinkona Indonesia Lestari – 
Indonesia), while isobutiryc acid and other 
materials for BSLT method were from sigma. 
All solvent chemicals used were of technical 
grade and redistilled before use. Compounds 
were identified with FT-IR, NMR, and ESI-
MS. 
 
2. 2. Methods 
2. 2. 1. Synthesis of Cinchonidine Isobutyrate 
Cinchonidine (588.7 mg, 2 mmol) was 
dissolved with dichloromethane and  added 
with 211.94 mg of  butyric acid and 412.66 
mg of DCC. They were stirred vigorously for 
1 hour. Later, the mixture was added with 
DMAP (30.628 mg) followed by continuous 
stirring for overnight. After that, DCU 
formed was filtered off and washed with 
NaHCO3. Crude extracts were purified over 
flash silica column chromatography using 
ethyl acetate 100%. 
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2. 2. 2. Identification of compounds 
Compounds were identified using Thin 
Layer Chromatography continued with 
spectrophotometer, NMR, FT-IR, and mass 
spectrometry. 
2. 2. 3. Hatching eggs Artemia salina Leach. 
Eggs of Artemia shrimp were submerged 
in water for 15-30 minutes. After that, the 
eggs were hatched in 10 L of water or water 
soluble synthetics with composition of 38 
grams of pure salt in 1 L of water for 24 
hours, covered with aluminum foil. Hatching 
temperature and pH were controlled. 
Hatching temperature was 25 C ᵒ -30C ᵒ and 
pH was set at ± 6-7. The eggs were incubated 
during 18-24 hours and the larvae were ready 
for the test after 48 hours (Subyakto, 2003). 
2. 2. 4. BSLT Method 
Cinchonidine 100 mg and Cinchonidine 
isobutyrate were diluted until the 
concentration reached 10µg/ml, 100 µ g/ml, 
500 µ g/ml, and 1000 µ g/ml. The control 
solution was also prepared (3 replicates). 
Serial solutions were transferred into 96-well 
microplates that contains the 3 ml sea water 
and 10 larvae shrimp and left for 24 hours. 
The results were analyzed to generate LC50 
values [13]. 
Data from probit number were put into a 
table. The X-axis was percentage of the 
larvae death and the Y-axis was log 
concentration. 
 
% Larvae mortality =  
(number of dead larvae)/(number of larvae of the 
experiment) × 100% 
 
After that, the results of the analysis were 
placed into the table and the results of the 
regression of Y = A + BX. LC50 Value is 
obtained by entering the value y = 50, then 
the value of LC50 was retrieved. 
 
3. RESULT AND DISCUSSION 
3. 1. Identified with spectrofotometer 
The molecular weight of cinchonidine 
isobutyrate was 364.22, based on the results 
of a spectrum of ESI-MS that showed m/z: 
365.89 (Figure 2). 
Identification of cinchonidine isobutyrate 
using FTIR showed peaks on 1734.01 cm
-1
  
for –C=O esther. Meanwhile, - CO- esther 
was characterized by the presence of a peak 
from  1190,08 cm
-1
from –CO- esther bond. 
Figure 3 ensured that there was no spectrum 
– OH of cinchonidine or – OH from 
isobutiryc acid. 
Spectra of 
1
H-NMR data of cinchonidine 
isobutyrate (Figure 4) indicated the presence 
of  two methyl groups of isobutyrate (3 "& 
4") at δ 1.14 (d) and  1.19  (d) methin oxy 
(H-9) became downfield  at  δ 6.50 ppm (d, 1 
H), indicating that chinconidine had been 
esterified.  The other signal indicated the 
presence of vinyl at δ 5,0 ppm, some 
aromatic protons at  δ 7.38 ppm (d, H-3’)H), 
7.59, ppm (t, H-6’),H, 7.71, ppm (t, H-7’), 
8.12  (d, H-8’), 8.24 (d, H-8’)  and 8.88 ppm 
(d, H-2”). Chemical shift data 1H-NMR was 
supported with  spectrum of 
13
C-NMR 
demonstrating that cinchonidine isobutyrate  
had been synthesized.  Spectrum of 
13
C-
NMR (Figure 5) also showed the presence of 
isobutyrate at δ18.3 (C-3”), 19.0 ppm (C-4”), 
C-2” 34.3 (C-2”) and 176.0 ppm. The 
presence of aromatic ring was shown at δ 
118.7 (C-5’),   123.5 (C-3’), 126.15,  127.0 
(C-6’),  C-7’  129.3 (C-7’) 130.6 (C-8’),, 
148.7 (C-2’), 150.0 (C-4’) ppm.
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Fig. 2. The Spectrum of ESI-MS. 
 
 
Fig. 3. FT-IR spectra of Cinchonidine Isobutyrate esther.
 
Fig. 4. Spektra 
1’
H-NMR. 
Fig. 5. Spektra 
13’
C-NMR 
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Table 1. Toxicity Test Result of BSLT for cinchonidine and cinchonidine isobutyrate (LC50) 
 
 
Fig. 6. Structure of Cinchonidine Isobutyrate. 
 
3. 2. The toxicity test against Artemia 
Larvae Saline Leach with Brine Shrimp 
Lethality Test method (BSLT) 
Cinchoninidine is a derivate of cinchona 
alkaloids. Cinchonidine had quinclidine and 
quinolone rings that have affinities on 
receptors for instance breast cancer cells 
MCF-7 [14,23]. Cinchonidine isobutyrate 
esther had specifications as required by the 
Lipinski rule, which is having molecular 
weight ≤ 500, Log P ≤ 5, bond the donor of 
H ≤ 5, bond acceptors of H ≤ 10, and the 
number of atoms N and O ≤ 10 [12]. 
Cinchonidine isobutyrate had molecular 
weight 364.22, Log P 4.05, no ties to H 
donor H, 4 H bond acceptors, only 2 atoms of 
N and 2 atoms of O. The higher its 
lipophilicity, the easier it penetrates cell 
membranes. Lipophilicity Ascension Theory 
was also supported by the existing research 
that proved that modification of quinine with 
fatty acids resulted in more toxicity against 
FM3A cells, compared to quinine [6]. Beside 
to increase lipophilicity, the reason to 
synthesize esthers as prodrugs was because 
when esther had penetrated the membrane, 
then it could be easily hydrolyzed by 
enzymes and become active. The usual 
enzymes found in the blood, liver, and other 
tissues and organs like carboxylesterases, 
Sample 
C 
(ppm) 
Log K Surviving 
Mortality/ 
Surviving 
Total 
Mortality/ 
Surviving 
Mortality 
(%) 
LC50 
( ppm) 
Blanko   10 10 10     
Ester sinchonidin 
isobutyrate 
10 1,0 4 3 2 21/9 21/50 29.58 75.6 
 100 2,0 10 9 10 1/29 22/41 34,92  
 500 2,7 3 5 4 18/12 40/12 76,92  
 1000 3,0 0 0 0 30/0 70/0 100,00  
Sinchonidine 10 1,0 10 10 10 3/27 3/49 5,77 99.2 
 100 2,0 10 10 10 7/23 10/23 31,25  
 500 2,7 11 10 10 31/0 41/0 100,00  
 1000 3,0 10 10 10 30/0 71/0 100,00  
1'
2'
3'
4'5'
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10'
8'
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3''
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acetylcholinesterases, butyrylcholinesterases, 
paraoxonases arylesterases can hydrolyze 
ester into cinchonidine and  isobutiryc acid 
[10, 18]. Isobutyryc acids as short chain fatty 
acids are used as a combination of anticancer 
prodrugs that are the most commonly used 
and also non-toxic. 
The results showed that the cinchonidine 
isobutyrate esther was more toxic than 
cinchonidine itself. Cinchonidine isobutyrate 
had LC50 of 75.56 ppm whereas IC50 of 
cinchonidine was 98.83 ppm. Other studies 
were conducted to compare IC50 values of 
cinchonidine against parasites like 
Trypanosoma brucei brucei bloodstream 
forms, l. mexicana mexicana promastigotes, 
and a chloroquine-sensitive strains of 
Plasmodium falciparum (3D7) and WI38 
(normal fibroblasts cells) find out its 
selectivity. The results showed that 
cinchonidine demonstrated high selectivity 
between fibroblast cells with a parasite [11]. 
This proved that cinchonidine was less harm 
than the others. Cinchonidine isobutyrate had 
not reached a good toxicity (LC50 ≤ 30 
ppm), but this experiment is referrable to the 
next research to increase more lipophilicity 
of cinchonidine with another acids or it 
should be tested on cancer cells in vitro. 
 
4. CONCLUSIONS  
The conclusion that can be resumed from 
this research was that the synthesis of 
cinchonidine isobutyrate could be done using 
DCC and DMAP for yield value of 27.7%. It 
requires optimization to get higher yield. The 
toxicity test using Larval Shrimp BSLT 
method against Artemia salina Leach showed 
that cinchonidine isobutyrate esther had LC50 
value of 75.16 ppm, indicating more toxicity 
than its original compound, cinchonidine 
with LC50 value of 99.2 ppm. It demonstrated 
that increasing lipophilicity could improve 
the pharmacological activity. 
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